TD Waterhouse Canada’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
EHC
SRIM
MG
OAM
TD Waterhouse Canada's NVO Position: Q2 2026 in Review
TD Waterhouse Canada increased its Novo Nordisk (NVO) stake by 4.8% in Q2 2026, buying an estimated $146K and bringing the position to 74,856 shares worth $3.65M. The position accounts for 0.01% of the portfolio, ranked #475.
TD Waterhouse Canada first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $27.4M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- TD Waterhouse Canada held 74,856 shares of Novo Nordisk worth $3.65M as of Q2 2026.
- TD Waterhouse Canada bought 3,399 Novo Nordisk shares in Q2 2026, an estimated $146K.
- Novo Nordisk made up 0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #475 holding.
- TD Waterhouse Canada first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
- TD Waterhouse Canada's Novo Nordisk position peaked at $27.4M in Q2 2024.
- 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.